Venture Capital

As MediciNova execs meet investors at the ROTH Conference, all eyes are on pivotal updates for its ALS, MS, and NAFLD drug candidates.

With a new film, 'One More Christmas,' Candace Cameron Bure solidifies her role as the architect of Great American Media's fast-growing holiday empire.

Red Bull Basement 2026 is open, challenging founders to build startups with AI, offering a $100k prize and a path from idea to the global stage.

With a new $60M fund and a former Lightspeed president, Boreal Ventures aims to turn great Canadian products into global commercial successes.

A new report projects explosive growth for Europe's solid-state battery sector, as automakers race to adopt safer, high-energy tech despite major hurdles.

After a failed reverse stock split, shipping firm OceanPal faces delisting. Can its ambitious AI subsidiary, SovereignAI, save it from the exchange?

A partnership between Biophytis and LynxKite leverages AI to fast-track therapies for sarcopenia and macular degeneration, backed by Singapore's RIE 2030 plan.

As it advances its brain cancer therapies, NeOnc Technologies hires a public company finance expert to steer its next growth phase and ensure fiscal rigor.

Aditxt's $36M acquisition of Ignite Proteomics aims to upend cancer therapy by analyzing protein activity, a high-stakes bet for the struggling innovator.

New research reveals a major disconnect: consumers, led by Gen Z, crave sustainable dining, but the foodservice industry is struggling to keep up.

A new iPSC-derived cell therapy from Unixell Biotech has gained FDA approval for clinical trials, offering a regenerative approach for millions with epilepsy.

At SXSW, Reckitt Catalyst and Serena Williams unveil a new cohort of U.S. entrepreneurs tackling America's deep-rooted healthcare access crisis.

The organic gardening firm returns to its origins with a new soil amendment, bringing a professional farmer's secret to home gardens via The Home Depot.

A new tech-heavy vape launches in Africa, targeting youth with social apps and custom features, just as regulators and health officials declare war on vaping.

The nation's largest beauty retailer is betting big on ingestible wellness, partnering with Cymbiotika to bring advanced supplements to over 1,000 stores.

Crane NXT adds Benchmark Electronics CEO Jeffrey Benck to its board, signaling a strategic pivot towards deeper tech expertise as a veteran director departs.

The organic kids' food brand reports impressive sales and a strong IPO, but investors are keenly watching its strategy for long-term profitability.

Universal Electronics is restructuring for profitability amid falling sales, raising questions about the future of the connected home market.

After a strategic pivot and R&D setbacks, Korro Bio secures an $85M lifeline to advance its novel RNA-editing drug for rare metabolic diseases.

A cult-favorite St. Louis creamery, fueled by a $6M investment from a franchise titan, is set to go national with an innovative model for franchisees.